前往化源商城

Drug Metabolism and Disposition 2014-12-01

Proton pump inhibitors inhibit methotrexate transport by renal basolateral organic anion transporter hOAT3.

Rym Chioukh, Marie-Sophie Noel-Hudson, Sandy Ribes, Natalie Fournier, Laurent Becquemont, Celine Verstuyft

文献索引:Drug Metab. Dispos. 42(12) , 2041-8, (2014)

全文:HTML全文

摘要

The coadministration of methotrexate (MTX) and proton pump inhibitors (PPIs) can result in a pharmacokinetic interaction that delays MTX elimination and subsequently increases the MTX blood concentrations. Human organic anion transporters (hOATs) are responsible for the renal tubular secretion of MTX and are thought to be involved in this drug interaction. The aim of this study was to evaluate the inhibitory potencies of PPIs on hOAT1 and hOAT3, which are the two isoforms of OATs predominantly expressed in kidney proximal tubules. Using stably transfected cell systems that express the uptake transporters human embryonic kidney (HEK)-hOAT1 and HEK-hOAT3, we analyzed the inhibitory potencies of omeprazole, lansoprazole, and pantoprazole on OAT-mediated [(3)H]estrone sulfate (ES), [(3)H]p-aminohippuric acid (PAH), and [(3)H]MTX uptake in vitro. hOAT3 is a high affinity transporter for MTX (Km = 21.17 ± 5.65 µM). Omeprazole, lansoprazole, and pantoprazole inhibited [(3)H]MTX uptake in HEK-hOAT3 cells with an IC50 of 6.8 ± 1.16, 1.14 ± 0.26, and 4.45 ± 1.62 µM, respectively, and inhibited the [(3)H]ES uptake in HEK-hOAT3 cells with an IC50 of 20.59 ± 4.07, 3.96 ± 0.96, and 7.89 ± 2.31 µM, respectively. Furthermore, omeprazole, lansoprazole, and pantoprazole exhibited inhibited PAH uptake on hOAT1 in a concentration-dependent manner (IC50 = 4.32 ± 1.26, 7.58 ± 1.06, and 63.21 ± 4.74 µM, respectively). These in vitro results suggest that PPIs inhibit [(3)H]MTX transport via hOAT3 inhibition, which most likely explains the drug-drug interactions between MTX and PPIs and should be considered for other OATs substrates.Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

相关化合物

结构式 名称/CAS号 全部文献
奥美拉唑 结构式 奥美拉唑
CAS:73590-58-6
二甲基亚砜 结构式 二甲基亚砜
CAS:67-68-5
二(2-羟乙基)亚氨基三(羟甲基)甲烷 结构式 二(2-羟乙基)亚氨基三(羟甲基)甲烷
CAS:6976-37-0
4-氨基马尿酸 结构式 4-氨基马尿酸
CAS:61-78-9
雌酚酮 结构式 雌酚酮
CAS:53-16-7
丙磺舒 结构式 丙磺舒
CAS:57-66-9
甲氨蝶呤 结构式 甲氨蝶呤
CAS:59-05-2
二水合氨甲嘌呤 结构式 二水合氨甲嘌呤
CAS:133073-73-1
N-[1-(2,3-二油酰氧基)丙基]-N,N,N-三甲基铵甲基-硫酸盐 结构式 N-[1-(2,3-二油酰氧基)丙基]-N,N,N-三甲基铵甲基-硫酸盐
CAS:144189-73-1
8-辛酰氧基芘-1,3,6-三磺酸三钠盐 结构式 8-辛酰氧基芘-1,3,6-三磺酸三钠盐
CAS:115787-84-3